Breaking News newswire

Monday, June 4, 2012

NASDAQ Morning Leader: MEDTOX Scientific (Nasdaq:MTOX) Moves on Merger News

New York, NY - June 4, 2012 ( Newswire), a leader in sector research for independent investors issues a trading alert for MEDTOX Scientific, Inc. (Nasdaq:MTOX), gaining $7.00 or (35.53%) to trade at $26.70, with a morning high of $26.88 on merger news.
MEDTOX Scientific (Nasdaq:MTOX), reported today that it had entered into a definitive merger agreement with Laboratory Corporation of America(R) Holdings (NYSE:LH). Under the terms of the agreement, LabCorp would acquire MEDTOX for a purchase price of $27.00 per share in cash, representing a total enterprise value of approximately $241,000,000. Newswire MEDTOX Scientific, Inc., headquartered in St. Paul, Minn., is a provider of high quality specialized laboratory testing services and on-site/point-of-collection testing (POCT) devices. The Company also supports customers with complete logistics, data and program management services. MEDTOX is a leader in providing esoteric laboratory testing services to hospitals and laboratories nationwide. This includes both central laboratory and bio-analytical testing for pharmaceutical clinical trials. MEDTOX develops and manufactures diagnostic devices for quick and economical on-site/point-of-collection analysis for drugs-of-abuse and therapeutic drugs, and provides employment drug screening and occupational health testing. For more information see
About is a leader in investor stock research by sector. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech,   China  stocks and agriculture.
Follow on Twitter!/Investorideas
Follow on Facebook
Get Free investor news and stock alerts at Investor Ideas
Sign Up:
Join Investor Ideas Get 13 of the best stock directories online;
Research tech stocks, oil and gas stocks, gold stocks, water stocks, renewable energy stocks and more
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Source -
Post a Comment